-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Theravance Biopharma (TBPH) amid Yupelri growth
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) Tops Q3 EPS by 20c, provides guidance
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) Tops Q2 EPS by 41c, provides guidance
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) Misses Q4 EPS by 11c ; Provides Outlook
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) PT Lowered to $15 at H.C. Wainwright
-
-
-
429,454 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

